Inventor · disambiguated record
Jérôme Moreaux
Also filed as: MOREAUX JEROME · MOREAUX JÉRÔME
6 granted patents·10 pending applications·2 citations·filing 2013–2022
65Inventor score
Files withCENTRE NAT RECH SCIENT9INST NAT SANTE RECH MED4HORIBA ABX SAS1INSERM INST NAT DE LA SANTÉ ET DE LA RE CHERCHE MÉDICALE1INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
16 records- 0171US10676791B2Methods for predicting response to DNA repair pathway inhibitors in diffuse large B-cell lymphomaINST NAT SANTE RECH MED·Filed 2015·Granted Jun 9, 2020·2 cites·10 claims
- 0253US2022396840A1Iron-score and in vitro method for identifying mantle cell lymphoma (mcl) subjects and therapeutic uses and methodsCENTRE NAT RECH SCIENT·Filed 2020·Application pending·0 cites
- 0353US2023220480A1Iron-score and in vitro method for identifying high risk dlbcl subjects and therapeutic uses and methodsCENTRE NAT RECH SCIENT·Filed 2020·Application pending·0 cites
- 0452US2025281502A1New drug applicationCENTRE NAT RECH SCIENT·Filed 2022·Application pending·0 cites
- 0550US2015218654A1Methods for predicting multiple myeloma treatment responseINSERM INST NAT DE LA SANTÉ ET DE LA RE CHERCHE MÉDICALE·Filed 2013·Application pending·0 cites
- 0650US2024368605A1Use of splice switching oligonucleotides for exon skipping-mediated knockdown of pim2INST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0749US10174380B2Methods for predicting multiple myeloma treatment responseINST NAT SANTE RECH MED·Filed 2013·Granted Jan 8, 2019·0 cites·2 claims
- 0849US2025281449A1Nitrogen-containing analogs of salinomycin for use in multiple myeloma (mm)CENTRE NAT RECH SCIENT·Filed 2022·Application pending·0 cites
- 0945US2023175068A1Prognosis method of acute myeloid leukaemiaCENTRE NAT RECH SCIENT·Filed 2021·Application pending·0 cites
- 1042US12071671B2Methods for the in vitro determination of the outcome and for the treatment of individuals having multiple myelomaCENTRE NAT RECH SCIENT·Filed 2019·Granted Aug 27, 2024·0 cites·8 claims
- 1139US11499197B2Prognosis method of multiple myelomaCENTRE NAT RECH SCIENT·Filed 2018·Granted Nov 15, 2022·0 cites·13 claims
- 1237US11578369B2Method for the in vitro prognosis of individuals having multiple myeloma and method for the treatment thereofCENTRE NAT RECH SCIENT·Filed 2017·Granted Feb 14, 2023·0 cites·6 claims
- 1337US2020041513A1Residual disease detection in multiple myelomaHORIBA ABX SAS·Filed 2017·Application pending·0 cites
- 1436US10662481B2Methods for predicting response to HDACi/DNMTi combination in multiple myelomaINST NAT SANTE RECH MED·Filed 2015·Granted May 26, 2020·0 cites·8 claims
- 1536US2019234950A1Method for the prognosis of multiple myelomaCENTRE NAT RECH SCIENT·Filed 2017·Application pending·0 cites
- 1635US2020330467A1Method and pharmaceutical compositions for the treatment of multiple myelomaINSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jérôme Moreaux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →